Lv1
10 积分 2023-03-19 加入
Comparative analysis of CDKI-related adverse events in older patients: a real-world data from the FDA adverse event reporting system database
14天前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
4个月前
已完结
中国丙肝流行特征与诊断研究进展
9个月前
已完结
2022年中国恶性肿瘤流行情况分析
11个月前
已完结
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study
1年前
已完结
Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-Line Treatment for Chinese Patients with Advanced Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
1年前
已完结
Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-Line Treatment for Chinese Patients with Advanced Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
1年前
已完结
Comparative Study Between Neostigmine Versus Sugammadex in Obese Patients Undergoing Laparoscopic Surgery
1年前
已完结
腹腔镜结直肠癌根治术老年患者应用舒更葡糖钠促进患者肺功能恢复的效果分析
1年前
已完结
皖公网安备34019202002308
